Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Amilo 5MER

Next Previous
X
Search
Drug Profile

Amilo 5MER

Alternative Names: Amilo-5MER

Latest Information Update: 04 Jun 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Hebrew University of Jerusalem
  • Developer Galmed Pharmaceuticals
  • Class Anti-inflammatories; Antirheumatics; Peptides; Small molecules
  • Mechanism of Action Protein aggregation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Phase I Inflammation; Inflammatory bowel diseases; Rheumatoid arthritis
  • Preclinical Multiple sclerosis; SARS-CoV-2 acute respiratory disease

Most Recent Events

  • 04 Apr 2024 Galmed Pharmaceuticals has patent protection for Amilo-5MER in the US, European Union, Australia and Japan
  • 04 Apr 2024 Yissum Research Ddevelopment Company of the Hebrew University of Jerusalem LTD has patent protection for "using the 5MER for the treatment of inflammatory diseases " in the US
  • 29 Mar 2023 Galmed Pharmaceuticals has patents pending for Amilo-5MER and anti-inflammatory compositions in Brazil, Korea and Canada

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top